Life | Free Full-Text | Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome | HTML
Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications - Clinical Therapeutics
NASH clinical research network scoring system. | Download Table
English | World Gastroenterology Organisation
Management of non-alcoholic fatty liver disease | The BMJ
Table 1 from Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia. | Semantic Scholar
Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design - ScienceDirect
Common endpoints of clinical trials in NAFLD/NASH | Download Table
NAFLD Activity Score (NAS) as per the NASH-CRN system. | Download Scientific Diagram
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study - The Lancet Gastroenterology & Hepatology
Table 1 from Nonalcoholic fatty liver disease: Synopsis of current developments. | Semantic Scholar
Liver Pathology: Steatohepatitis | Liver Fellow Network
NASH model evaluated by NASH Research Network Scoring System... | Download Scientific Diagram
Non-Alcoholic Steatohepatitis (NASH) information for healthcare providers | Labcorp
Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease - Journal of Hepatology
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis - ScienceDirect
NASH CRN NAFLD activity scoring system | Download Table
Grading and Staging NAFLD
Nonalcoholic fatty liver disease: Definitions, risk factors, and workup - Puri - 2012 - Clinical Liver Disease - Wiley Online Library
DDTBMQ000105 LOI Submission NASH
Table 1 from Pathology of Non-Alcoholic Fatty Liver Disease | Semantic Scholar
NAFLD SCORE
Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis - Tincopa - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library
Frontiers | Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments
